Literature DB >> 12721886

The global burden of measles in the year 2000--a model that uses country-specific indicators.

Claudia E Stein1, Maureen Birmingham, Mary Kurian, Philippe Duclos, Peter Strebel.   

Abstract

The estimation of the global burden of measles is challenging in the absence of reliable and comparable surveillance systems worldwide. A static model is described that enables estimation of measles morbidity, mortality, and disability for the year 2000 on the basis of country-specific information (i.e., demographic profile, vaccine coverage, and estimates of case-fatality ratios). This approach estimated a global incidence of 39.9 million measles cases, 777,000 deaths, and 28 million disability-adjusted life years. The World Health Organization regions of Africa and Southeast Asia had 70% of incident cases and 84% of measles-related deaths; 11 countries alone (Afghanistan, Burkina Faso, Democratic Republic of the Congo, Ethiopia, India, Indonesia, Niger, Nigeria, Pakistan, Somalia, Uganda) account for 66% of deaths. This approach quantifies the measles burden by considering country-specific indicators, which can be updated, permitting an assessment of country, regional, and global changes in the burden associated with measles infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12721886     DOI: 10.1086/368114

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  30 in total

1.  Immune response to 1 and 2 dose regimens of measles vaccine in Pakistani children.

Authors:  Hamidah Hussain; Dure Samin Akram; Subhash Chandir; Aamir J Khan; Ashraf Memon; Neal A Halsey
Journal:  Hum Vaccin Immunother       Date:  2013-08-08       Impact factor: 3.452

2.  Measles deaths in Nepal: estimating the national case-fatality ratio.

Authors:  Anand B Joshi; Elizabeth T Luman; Robin Nandy; Bal K Subedi; Jayantha B L Liyanage; Thomas F Wierzba
Journal:  Bull World Health Organ       Date:  2009-06       Impact factor: 9.408

3.  Assessment of the epidemiology and burden of measles in Southern Mozambique.

Authors:  Inácio Mandomando; Denise Naniche; Marcela F Pasetti; Lilian Cuberos; Sergi Sanz; Xavier Vallès; Betuel Sigauque; Eusébio Macete; Delino Nhalungo; Karen L Kotloff; Myron M Levine; Pedro L Alonso
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

4.  Knowledge and skills of neonatal resuscitation of health professionals at a university teaching hospital of Northwest Ethiopia.

Authors:  Endale Gebreegziabher; Adugna Aregawi; Habtamu Getinet
Journal:  World J Emerg Med       Date:  2014

5.  Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.

Authors:  Man Ki Song; Christofer J Vindurampulle; Alejandra V E Capozzo; Jeffrey Ulmer; John M Polo; Marcela F Pasetti; Eileen M Barry; Myron M Levine
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  High pathogenicity of wild-type measles virus infection in CD150 (SLAM) transgenic mice.

Authors:  Caroline I Sellin; Nathalie Davoust; Vanessa Guillaume; Dominique Baas; Marie-Françoise Belin; Robin Buckland; T Fabian Wild; Branka Horvat
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

7.  Inhibition of ubiquitination and stabilization of human ubiquitin E3 ligase PIRH2 by measles virus phosphoprotein.

Authors:  Mingzhou Chen; Jean-Claude Cortay; Ian R Logan; Vasileia Sapountzi; Craig N Robson; Denis Gerlier
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Episodic outbreaks bias estimates of age-specific force of infection: a corrected method using measles as an example.

Authors:  M J Ferrari; A Djibo; R F Grais; B T Grenfell; O N Bjørnstad
Journal:  Epidemiol Infect       Date:  2009-06-19       Impact factor: 2.451

9.  Gene expression patterns in dendritic cells infected with measles virus compared with other pathogens.

Authors:  Michael J Zilliox; Giovanni Parmigiani; Diane E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

10.  Seroprevalence against the measles virus after vaccination or natural infection in an adult population in Madinah, Saudi Arabia.

Authors:  Waleed H Mahallawi; Nadir A Ibrahim
Journal:  Hum Vaccin Immunother       Date:  2021-02-11       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.